ramani

Avillion appoints chief business officer

pharmafile | May 31, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Avillion 

Venture capitalist firm Avillion has announced the expansion of its leadership team with the appointment of Ramani Varanasi as chief business officer.

Ramani is an accomplished business executive, bringing over 18 years of biotech and pharma industry experience to Avillion. She has a distinguished track record in structuring, negotiating and executing successful strategic alliances, licensing agreements and M&A transactions.

Over her career, Ramani has held research and senior level positions in business & corporate development including at Merck, Millennium/Takeda, Momenta Pharmaceuticals, Archemix and RXi Pharmaceuticals. 

Advertisement

Lewis Cameron, chief executive of Avillion, commented: “We are excited to have Ramani on the Avillion team, where our key focus is the execution of co-development and financing deals with pharma and biotech companies. Her experience and leadership in business and corporate development will support Avillion in its goal of establishing partnerships on late-stage clinical assets.”

Related Content

No items found
The Gateway to Local Adoption Series

Latest content